Search

Your search keyword '"Qingqin S. Li"' showing total 83 results

Search Constraints

Start Over You searched for: Author "Qingqin S. Li" Remove constraint Author: "Qingqin S. Li"
83 results on '"Qingqin S. Li"'

Search Results

1. Characterization of APOE Christchurch carriers in 455,306 UK Biobank participants

2. Personalized relapse prediction in patients with major depressive disorder using digital biomarkers

3. A standardized workflow for long-term longitudinal actigraphy data processing using one year of continuous actigraphy from the CAN-BIND Wellness Monitoring Study

4. Genome-wide association study of abnormal elevation of ALT in patients exposed to atabecestat

5. Meta-analysis of epigenome-wide association studies of major depressive disorder

6. Using brain cell-type-specific protein interactomes to interpret neurodevelopmental genetic signals in schizophrenia

7. Identifying the Common Genetic Basis of Antidepressant Response

8. Assessment of suicide attempt and death in bipolar affective disorder: a combined clinical and genetic approach

9. Circulating microRNA associated with future relapse status in major depressive disorder

10. Differentially expressed genes in Alzheimer’s disease highlighting the roles of microglia genes including OLR1 and astrocyte gene CDK2AP1

11. Integrated miRNA-Seq and mRNA-Seq Study to Identify miRNAs Associated With Alzheimer’s Disease Using Post-mortem Brain Tissue Samples

12. Genetic Overlap Between Alzheimer’s Disease and Bipolar Disorder Implicates the MARK2 and VAC14 Genes

13. Risk of Midlife Stroke After Adverse Pregnancy Outcomes: The FinnGen Study

14. Extended familial risk of suicide death is associated with younger age at death and elevated polygenic risk of suicide

15. A standardized workflow for long-term longitudinal actigraphy data processing: One year of continuous actigraphy from the CAN-BIND Wellness Monitoring Study

16. Characterization ofAPOEChristchurch carriers in 455,306 UK Biobank participants

17. Predictive modeling of treatment resistant depression using data from STAR*D and an independent clinical study.

18. Comparative effect of metformin versus sulfonylureas with dementia and Parkinson’s disease risk in US patients over 50 with type 2 diabetes mellitus

19. Assessment of suicide attempt and death in bipolar affective disorder: a combined clinical and genetic approach

20. Rare protein‐coding variants implicate genes involved in risk of suicide death

21. Identifying the Common Genetic Basis of Antidepressant Response

22. Sex-Dependent Shared and Nonshared Genetic Architecture Across Mood and Psychotic Disorders

23. Dissecting the Shared Genetic Architecture of Suicide Attempt, Psychiatric Disorders, and Known Risk Factors

24. Integrative analysis of DNA methylation and gene expression identifies genes associated with biological aging in Alzheimer's disease

26. Exploring the genetic overlap of suicide-related behaviors and substance use disorders

27. Daily steps and depressive symptoms: A longitudinal evaluation of patients with major depressive disorder in the precision medicine in mental health care study

28. Phenotypic analysis of 23andMe survey data: Treatment-resistant depression from participants’ perspective

29. Characterization of Age and Polarity at Onset in Bipolar Disorder

30. A Comparison of Ten Polygenic Score Methods for Psychiatric Disorders Applied Across Multiple Cohorts

31. Genome-wide association study of more than 40,000 bipolar disorder cases provides new insights into the underlying biology

32. Epigenome-wide association study of Alzheimer’s disease replicates 22 differentially methylated positions and 30 differentially methylated regions

33. Genome-wide association study of over 40,000 bipolar disorder cases provides new insights into the underlying biology

34. Genome-wide association study of more than 40,000 bipolar disorder cases provides new insights into the underlying biology

35. Genome-wide association study and polygenic risk score analysis of esketamine treatment response

36. The Genetics of the Mood Disorder Spectrum: Genome-wide Association Analyses of More Than 185,000 Cases and 439,000 Controls

37. Harnessing peripheral DNA methylation differences in the Alzheimer’s Disease Neuroimaging Initiative (ADNI) to reveal novel biomarkers of disease

38. Neurexin 1 variants as risk factors for suicide death

39. Rare protein coding variants implicate genes involved in risk of suicide death

40. Additional file 1 of Harnessing peripheral DNA methylation differences in the Alzheimer’s Disease Neuroimaging Initiative (ADNI) to reveal novel biomarkers of disease

41. Does Childhood Trauma Moderate Polygenic Risk for Depression?

42. Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression

44. The relationship between plasma serotonin and kynurenine pathway metabolite levels and the treatment response to escitalopram and desvenlafaxine

45. Genomic Relationships, Novel Loci, and Pleiotropic Mechanisms across Eight Psychiatric Disorders

46. The association of clinical phenotypes to known AD/FTD genetic risk loci and their inter-relationship

47. Correction: Genome-wide gene-environment analyses of major depressive disorder and reported lifetime traumatic experiences in UK Biobank

48. Applying polygenic risk scoring for psychiatric disorders to a large family with bipolar disorder and major depressive disorder

49. P4‐245: PHENOME‐WIDE ASSOCIATION AND EPIGENETIC INTERROGATION OF AD/FTD RISK LOCI

50. P3‐120: DNA METHYLATION DYNAMICS IN ALZHEIMER'S DISEASE: DEVELOPMENT OF BIOMARKERS AND NOVEL DRUG TARGETS USING ADNI EPIGENETIC DATA

Catalog

Books, media, physical & digital resources